Tech Company Financing Transactions
PluroGen Therapeutics Funding Round
PluroGen Therapeutics, based in Norristown, raised $300 thousand from private investors.
Transaction Overview
Company Name
Announced On
1/13/2014
Transaction Type
Venture Equity
Amount
$300,000
Round
Series B
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for solicitation details, if applicable.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2495 General Armistead Ave.
Norristown, PA 19403
USA
Norristown, PA 19403
USA
Phone
Website
Email Address
Overview
PluroGen Therapeutics, Inc. is commercializing new and superior therapeutic products for improved patient outcomes in tissue management and repair. Our products are based on ourpatented, advanced topical drug delivery and drug efficacy enhancement technology platform.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Neal Koller
Chief Medical Officer
Glenn Warden
Browse more venture capital transactions:
Prev: 1/13/2014: onFocus Healthcare venture capital transaction
Next: 1/13/2014: Rebellion Photonics venture capital transaction
Share this article
About Our Venture Capital Transactions Database
Our team works diligently to record tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs